Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Oral Treatment of Glucocorticoid-Induced Diabetes Mellitus: A Systematic Review

Research output: Contribution to journalLetterpeer-review

DOI

  1. Determinants of sexual function and dysfunction in men and women with stroke: A systematic review

    Research output: Contribution to journalReviewpeer-review

  2. Clinical use of the co-formulation of insulin degludec and insulin aspart

    Research output: Contribution to journalReviewpeer-review

  1. Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Drug-drug interaction between warfarin and statins: A Danish cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Glucocorticoid-induced diabetes mellitus (GIDM) is a well-known and common metabolic side effect of glucocorticoid (GC) treatment. The risk of developing GIDM in non-diabetic patients who receive systemic GCs, was evaluated in a metanalysis and found to be 18.6%. GIDM is potential life-threatening, and hyperglycaemia, even mild, in hospitalized patients is associated with both increased mortality and increased morbidity. Often, insulin is the preferred treatment option. However, insulin is a high-risk drug and to patients without previously known diabetes, initiation of insulin therapy requires training in blood glucose measurements and insulin injections.

Original languageEnglish
Article numbere13529
JournalInternational Journal of Clinical Practice
Volume74
Issue number8
ISSN1368-5031
DOIs
Publication statusPublished - Aug 2020

ID: 59837607